Please assess the completion status of the following clinical trial:

Trial Title: Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female Japanese participants ≥20 years of age~* Diagnosis of chronic kidney disease (CKD) based on an estimated glomerular filtration rate ≤60 milliliters per minute per 1.73 meters squared (mL/min/1.73 m\^2)~* Hemoglobin (Hb) ≤10.5 grams per deciliter (g/dL)~* Not currently being treated with dialysis and not expected to start dialysis within 3 months of screening~Exclusion Criteria:~* Anemia due to a cause other than CKD or presence of active bleeding or recent blood loss~* Sickle cell disease, myelodysplastic syndromes, bone marrow fibrosis, hematologic malignancy, myeloma, hemolytic anemia, thalassemia, or pure red cell aplasia~* Red blood cell transfusion within 4 weeks prior to or during screening~* Intravenous iron within 4 weeks prior to or during screening~* Any use of erythropoiesis-stimulating agents within 6 weeks prior to or during screening

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vadadustat, Dose 1 (Type: EXPERIMENTAL): Daily oral dose
- Vadadustat, Dose 2 (Type: EXPERIMENTAL): Daily oral dose
- Vadadustat, Dose 3 (Type: EXPERIMENTAL): Daily oral dose
- Placebo (Type: PLACEBO_COMPARATOR): Daily oral dose

Based on this trial design, predict the completion outcome and termination type (if applicable).